Cargando…

Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor

BACKGROUND: Checkpoint kinase 1 and 2 (Chk1/Chk2), and the Aurora kinases play a critical role in the activation of the DNA damage response and mitotic spindle checkpoints. We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Massey, Andrew J., Borgognoni, Jenifer, Bentley, Carol, Foloppe, Nicolas, Fiumana, Andrea, Walmsley, Lee
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956624/
https://www.ncbi.nlm.nih.gov/pubmed/20976184
http://dx.doi.org/10.1371/journal.pone.0013123
_version_ 1782188163413835776
author Massey, Andrew J.
Borgognoni, Jenifer
Bentley, Carol
Foloppe, Nicolas
Fiumana, Andrea
Walmsley, Lee
author_facet Massey, Andrew J.
Borgognoni, Jenifer
Bentley, Carol
Foloppe, Nicolas
Fiumana, Andrea
Walmsley, Lee
author_sort Massey, Andrew J.
collection PubMed
description BACKGROUND: Checkpoint kinase 1 and 2 (Chk1/Chk2), and the Aurora kinases play a critical role in the activation of the DNA damage response and mitotic spindle checkpoints. We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between these two checkpoints. PRINCIPAL FINDINGS: Fragment screening, structure guided design, and kinase cross screening resulted in the identification of a novel, potent small molecule kinase inhibitor (VER-150548) of Chk1 and Chk2 kinases with IC(50)s of 35 and 34 nM as well as the Aurora A and Aurora B kinases with IC(50)s of 101 and 38 nM. The structural rationale for this kinase specificity could be clearly elucidated through the X-ray crystal structure. In human carcinoma cells, VER-150548 induced reduplication and the accumulation of cells with >4N DNA content, inhibited histone H3 phosphorylation and ultimately gave way to cell death after 120 hour exposure; a phenotype consistent with cellular Aurora inhibition. In the presence of DNA damage induced by cytotoxic chemotherapeutic drugs, VER-150548 abrogated DNA damage induced cell cycle checkpoints. Abrogation of these checkpoints correlated with increased DNA damage and rapid cell death in p53 defective HT29 cells. In the presence of DNA damage, reduplication could not be observed. These observations are consistent with the Chk1 and Chk2 inhibitory activity of this molecule. CONCLUSIONS: In the presence of DNA damage, we suggest that VER-150548 abrogates the DNA damage induced checkpoints forcing cells to undergo a lethal mitosis. The timing of this premature cell death induced by Chk1 inhibition negates Aurora inhibition thereby preventing re-entry into the cell cycle and subsequent DNA reduplication. This novel kinase inhibitor therefore serves as a useful chemical probe to further understand the temporal relationship between cell cycle checkpoint pathways, chemotherapeutic agent induced DNA damage and cell death.
format Text
id pubmed-2956624
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29566242010-10-25 Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor Massey, Andrew J. Borgognoni, Jenifer Bentley, Carol Foloppe, Nicolas Fiumana, Andrea Walmsley, Lee PLoS One Research Article BACKGROUND: Checkpoint kinase 1 and 2 (Chk1/Chk2), and the Aurora kinases play a critical role in the activation of the DNA damage response and mitotic spindle checkpoints. We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between these two checkpoints. PRINCIPAL FINDINGS: Fragment screening, structure guided design, and kinase cross screening resulted in the identification of a novel, potent small molecule kinase inhibitor (VER-150548) of Chk1 and Chk2 kinases with IC(50)s of 35 and 34 nM as well as the Aurora A and Aurora B kinases with IC(50)s of 101 and 38 nM. The structural rationale for this kinase specificity could be clearly elucidated through the X-ray crystal structure. In human carcinoma cells, VER-150548 induced reduplication and the accumulation of cells with >4N DNA content, inhibited histone H3 phosphorylation and ultimately gave way to cell death after 120 hour exposure; a phenotype consistent with cellular Aurora inhibition. In the presence of DNA damage induced by cytotoxic chemotherapeutic drugs, VER-150548 abrogated DNA damage induced cell cycle checkpoints. Abrogation of these checkpoints correlated with increased DNA damage and rapid cell death in p53 defective HT29 cells. In the presence of DNA damage, reduplication could not be observed. These observations are consistent with the Chk1 and Chk2 inhibitory activity of this molecule. CONCLUSIONS: In the presence of DNA damage, we suggest that VER-150548 abrogates the DNA damage induced checkpoints forcing cells to undergo a lethal mitosis. The timing of this premature cell death induced by Chk1 inhibition negates Aurora inhibition thereby preventing re-entry into the cell cycle and subsequent DNA reduplication. This novel kinase inhibitor therefore serves as a useful chemical probe to further understand the temporal relationship between cell cycle checkpoint pathways, chemotherapeutic agent induced DNA damage and cell death. Public Library of Science 2010-10-18 /pmc/articles/PMC2956624/ /pubmed/20976184 http://dx.doi.org/10.1371/journal.pone.0013123 Text en Massey et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Massey, Andrew J.
Borgognoni, Jenifer
Bentley, Carol
Foloppe, Nicolas
Fiumana, Andrea
Walmsley, Lee
Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title_full Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title_fullStr Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title_full_unstemmed Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title_short Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
title_sort context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956624/
https://www.ncbi.nlm.nih.gov/pubmed/20976184
http://dx.doi.org/10.1371/journal.pone.0013123
work_keys_str_mv AT masseyandrewj contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor
AT borgognonijenifer contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor
AT bentleycarol contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor
AT foloppenicolas contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor
AT fiumanaandrea contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor
AT walmsleylee contextdependentcellcyclecheckpointabrogationbyanovelkinaseinhibitor